Liquidia Technologies Inc (LQDA) has released an update.
Liquidia Corporation, a Delaware-based company, announced an update on the New Drug Application for their product YUTREPIA (treprostinil) inhalation powder on January 25, 2024, through a press release.
For further insights into LQDA stock, check out TipRanks’ Stock Analysis page.
